About Gujarat Kidney & Super Speciality
It is a healthcare service provider offering specialized treatment in kidney-related diseases, dialysis services, and other super speciality medical procedures. The hospital is equipped with modern infrastructure, advanced diagnostic facilities, and experienced medical professionals.The company focuses on providing affordable yet quality healthcare services. Its revenue primarily comes from patient services, dialysis treatments, surgeries, and hospital stays. The management has highlighted expansion and capacity enhancement as part of its long-term growth strategy.IPO Details
- IPO Open Date: 29 November 2024
- IPO Close Date: 3 December 2024
- IPO Type: SME IPO
- Issue Price: ₹114 per share
- Lot Size: As per SME norms
Gujarat Kidney IPO GMP Today (Grey Market Premium Update)
During the subscription period, the IPO GMP showed moderate activity in the grey market. The GMP was reported around ₹1 per share near the closing days of the subscription.This indicated a small premium over the issue price, suggesting cautious optimism among traders. A low but positive GMP generally reflects neutral to mildly positive market sentiment.Investors should note that IPO GMP is unofficial and speculative. It is not regulated and may fluctuate daily based on demand and market conditions.Subscription & Market Sentiment
This IPO witnessed decent subscription from retail investors. Healthcare as a sector typically attracts long-term investors due to steady demand and business stability.Market sentiment during the IPO period was stable. The broader market conditions were supportive, but investors remained selective, especially in SME offerings.The modest GMP suggested that investors were evaluating the fundamentals carefully rather than chasing listing gains aggressively.Financial Performance Overview
The company reported steady revenue growth over the past few financial years. Profit margins were stable, supported by increasing patient volumes and improved operational efficiency.Healthcare infrastructure demand continues to rise in Tier-2 and Tier-3 cities, which may provide growth opportunities for the company in the future.Listing Performance
The shares listed around ₹120, reflecting a small premium over the issue price of ₹114. This aligned closely with the grey market expectations and indicated realistic pricing.Investors who applied for listing gains saw limited but positive returns. Long-term investors may evaluate performance based on quarterly growth and hospital expansion plans.Is Gujarat Kidney & Super Speciality IPO Good for Investment?
The IPO was considered suitable for investors looking for exposure to the healthcare sector through SME listings. However, SME IPOs carry relatively higher risk and lower liquidity compared to mainboard IPOs.Investors should always consider company fundamentals, valuation, sector outlook, and risk tolerance before investing.Watch Our Detailed IPO Analysis
For a complete breakdown including financial ratios, risk factors, and future growth prospects, watch our detailed IPO review video below:Disclaimer
IPO GMP is unofficial grey market data and should not be considered as investment advice. Investors are advised to consult financial advisors before making any investment decisions.